These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 28385388)
1. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene. Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4. Ma C; Xu B; Husaiyin S; Wang L; Wusainahong K; Ma J; Zhu K; Niyazi M Biomed Pharmacother; 2017 Aug; 92():586-594. PubMed ID: 28577497 [TBL] [Abstract][Full Text] [Related]
3. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. Wang N; Zhou Y; Zheng L; Li H Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973 [TBL] [Abstract][Full Text] [Related]
4. DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer. Liu Z; Wu M; Shi H; Huang C; Luo S; Song X J Cell Biochem; 2019 Jun; 120(6):10228-10238. PubMed ID: 30582201 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer. Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma. Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2. Qin X; Wan Y; Wang S; Xue M Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Luo M; Shen D; Zhou X; Chen X; Wang W Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer. Luo M; Shen D; Wang W; Xian J Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma. Luo L; Zhang H; Nian S; Lv C; Ni B; Wang D; Tian Z Int J Gynecol Cancer; 2017 Sep; 27(7):1422-1430. PubMed ID: 28604457 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Wang LQ; Zhang Y; Yan H; Liu KJ; Zhang S Biochem Biophys Res Commun; 2015 Apr; 459(3):515-20. PubMed ID: 25747718 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer. Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739 [TBL] [Abstract][Full Text] [Related]
14. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer. Pang H; Yue X Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495 [TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer. Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7. Deng B; Zhang Y; Zhang S; Wen F; Miao Y; Guo K Tumour Biol; 2015 Sep; 36(10):8065-73. PubMed ID: 25976503 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification. Xu Y; Chen X; Lin L; Chen H; Yu S; Li D Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710 [TBL] [Abstract][Full Text] [Related]
18. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681 [TBL] [Abstract][Full Text] [Related]
19. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells. Sathyanarayanan A; Chandrasekaran KS; Karunagaran D Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466 [TBL] [Abstract][Full Text] [Related]
20. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis. He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]